StockData

Electromedical Technologies, Inc (EMED) stock

EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.00+0.00 (+9900.00%)

Close on Oct 19, 2026Market cap $68.10KP/E –Yield –

Electromedical Technologies r&d expenses

Research and development expenses are spending on new products and technology.

Electromedical Technologies's R&D Expenses for the twelve months ending Dec 31, 2020 was $31.60K, down 61.9% year over year. For fiscal 2023 it was $231.43K, up 150.7% from the year before. The highest annual figure on record is $231.43K in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2023Dec 31, 2023$231.43K+150.7%
FY2022Dec 31, 2022$92.30K-57.1%
FY2021Dec 31, 2021$215.32K+581.4%
FY2020Dec 31, 2020$31.60K-61.9%
FY2019Dec 31, 2019$82.85K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$31.60K+117.5%
Q3 FY2020Sep 30, 2020$0-100.0%
Q2 FY2020Jun 30, 2020$4.00K–
Q4 FY2019Dec 31, 2019$47.24K–
Q3 FY2019Sep 30, 2019$14.53K–
Q2 FY2019Jun 30, 2019$21.08K–

More Electromedical Technologies figures

See a number that looks wrong?